Search clinical trials for: Modafinil

Total 210 results

University Health Network, Toronto

Not yet recruiting

Modafinil and Exercise for Post Stroke Fatigue (MODEX)

Stroke | Fatigue | Exercise | Modafinil
University of California, Davis

Recruiting

Investigation of Locus Coeruleus Function in Sustained Attention (LC)

Attention - no Condition is Being Assessed - Healthy Adults

United States
Kuwait University

Not yet recruiting

Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy (CP)

Cerebral Palsy | Neurodevelopmental Disorders

Kuwait
Harmony Biosciences, LLC

Recruiting

WAKIX® (Pitolisant) Pregnancy Registry

Pregnancy Related | Narcolepsy

United States
Joshua Woolley, MD/PhD

Recruiting

Psilocybin Therapy for Chronic Low Back Pain (POP)

Chronic Low-back Pain

United States
Ottawa Hospital Research Institute
The Ottawa Hospital; Bruyere Research Institute

Not yet recruiting

Modafinil to Improve Fatiguability (MODIFY)

Fatigue | Cancer-related Problem/Condition | Cancer-related Cognitive Difficulties

Canada
Maastricht University Medical Center
Erasmus Medical Center; Jules Bordet Institute; Academisch Ziekenhuis Maastricht

Recruiting

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

Unspecified Adult Solid Tumor, Protocol Specific

Netherlands, Belgium
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Recruiting

Substance Abuse Pre-Treatment Screening Study

Alcohol Dependence | Substance Abuse | Cocaine Dependence | Opiate Dependence | Cocaine Abuse

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Modafinil Tablets 200 mg to Provigil® Tablets 200 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg

Healthy

United States
Luo Cong

Completed

The Prognostic Impact of Surufatinib for the Treatment of Advanced Pancreatic Ductal Adenocarcinoma

Pancreatic Cancer

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer

Fatigue | Head And Neck Cancer

United States
Cephalon, Inc.

Terminated

The Nuvigil and Provigil Pregnancy Registry

Obstructive Sleep Apnea | Narcolepsy | Shift Work Sleep Disorder

United States
Vanderbilt University Medical Center
National Center for Advancing Translational Sciences (NCATS)

Active, not recruiting

Modafinil and Cognitive Function in POTS

Postural Tachycardia Syndrome

United States
Tuberculosis Research Centre, India
All India Institute of Medical Sciences, Bhubaneswar; Institute of Child Health... and other collaborators

Suspended

BCG Revaccination in Children and Adolescents (BRiC)

Tuberculosis | Tuberculosis Infection

India
Uppsala University
Karolinska Institutet; Oslo University Hospital; Göteborg University; New York... and other collaborators

Terminated

Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT (MINOCA-BAT)

Myocardial Infarction With Non-obstructive Coronary Arteries

Norway, Sweden, Australia, New Zealand, Spain
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma

Fatigue

United States
The Cooper Health System

Completed

Modafinil to Prevent Postoperative Cognitive Decline

Postoperative Cognitive Dysfunction
Satish R. Raj
National Center for Advancing Translational Sciences (NCATS)

Active, not recruiting

Treatment of Orthostatic Intolerance

Tachycardia | Chronic Orthostatic Intolerance

United States
Pfizer
Pierre Fabre Laboratories

Active, not recruiting

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Advanced Solid Tumors | Metastatic Melanoma

United States, Spain, Belgium, Canada, Netherlands
Genuine Research Center, Egypt
Chemipharm Pharmaceutical Industries, Egypt

Completed

Bioequivalence Study of Modafinil From Bravamax 200 mg Scored Tablets (Chemipharm Pharmaceutical Industries, Egypt) Versus Vigil 200 mg Tablets (Teva GmbH, Germany)

Healthy

Egypt
Emory University
American Academy of Sleep Medicine

Completed

Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia

Idiopathic Hypersomnia | Narcolepsy Without Cataplexy

United States
The University of Texas Health Science Center,...

Completed

Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention

Cocaine-Related Disorders

United States
Mclean Hospital

Completed

Novel Cross-Species Neurophysiological Assays of Reward and Cognitive Domains

Translational Electrophysiology

United States
University of Michigan
Patient-Centered Outcomes Research Institute; University of Washington; National...

Completed

Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue (COMBO-MS)

Multiple Sclerosis

United States
Baylor College of Medicine

Completed

Complementary Combination Therapy for Cocaine Dependence

Cocaine Dependence

United States
University of California, San Diego

Completed

Modafinil Effects on EEG Biomarkers of Reward and Motivation

Healthy Adults

United States
Gradalis, Inc.

Completed

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

Non Small Cell Lung Cancer | Liver Cancer | Ewings Sarcoma

United States
Cephalon, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Traumatic Brain Injury

United States, Germany, Italy, Spain
Cephalon, Inc.

Terminated

Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Traumatic Brain Injury

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Pharmacotherapy & CM for Opioid and Cocaine Dependence

Cocaine Dependence

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Narcolepsy

United States, Finland
University of Arkansas

Completed

Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)

Parkinson Disease

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors

Fatigue | Cognition Disorders | Brain Tumors | Nervous System Tumors

United States
NYU Langone Health
Cephalon

Withdrawn

Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies (Armodafinil)

Parkinsons Disease | Lewy Bodies Disease

United States
University of South Florida
National Cancer Institute (NCI)

Completed

Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor

Fatigue | Brain and Central Nervous System Tumors | Neurotoxicity | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its Treatment

United States
Shire

Completed

Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

Sleep Deprivation

United States
Takeda

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults

Healthy Volunteers

United States
King Faisal Specialist Hospital & Research Center

Completed

Modafinil for Wakefulness in the Critical Care Units

COVID-19 | Critical Illness | Cognitive Dysfunction

Saudi Arabia
Johns Hopkins University
Patient-Centered Outcomes Research Institute

Completed

Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis (TRIUMPHANT-MS)

Fatigue in Multiple Sclerosis

United States
Manhattan Psychiatric Center

Withdrawn

Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder

Schizophrenia
M.D. Anderson Cancer Center

Terminated

Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning

Brain Tumor

United States
Theranexus

Completed

Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients

Narcolepsy

France, Belgium
Jonsson Comprehensive Cancer Center
Cephalon

Completed

Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer

Fatigue | Brain and Central Nervous System Tumors | Cognitive/Functional Effects

United States
Kyle Kampman
National Institute on Drug Abuse (NIDA)

Completed

Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence (Mod-Nal)

Alcoholism | Alcohol-Related Disorders | Cocaine-Related Disorders

United States
The Mind Research Network

Completed

Modafinil for the Treatment of Alcohol Use Disorders

Alcohol Use Disorder

United States
University of California, San Francisco
The Dana Foundation

Terminated

Antipsychotic Effects on Brain Function in Schizophrenia (APD)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

Cognitive Behavioral Therapy With or Without Armodafinil in Treating Cancer Survivors With Insomnia and Fatigue After Chemotherapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
Stanford University

Withdrawn

Treatment for Cognitive Impairment in Depression (T-CID)

Major Depressive Disorder
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Modafinil vs Placebo for the Treatment of Methamphetamine Dependence (Modafinil)

Methamphetamine Dependence

United States

Search clinical trials for: Modafinil

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations